Lung cancer and melanoma patients immunized with this formula doubled their chances of surviving three years, according to a ...

The UC Santa Cruz RNA Center hosted a premiere screening of “Cracking the Code: Phil Sharp and the Biotech Revolution” at the ...

In a city, coworking hubs bring people and ideas together. Inside cancer cells, similar hubs form—but instead of fueling ...

Brown didn't think anyone would take her serious after leaving the automotive space but it led her to co-found biotech ...

Innorna Co., a Chinese developer of messenger RNA drugs backed by buyout firm CDH Investments, is planning an initial public ...

Breakthroughs in RNA editing and radioligand therapies are poised to take biotech into a new era – driving innovation, growth and new investment opportunities Biotechnology is entering a dynamic new ...

A new method to detect ribonucleic acid (RNA) without needing any complex lab procedures or heating equipment has been ...

“Our findings show that RNA-based testing can uncover hidden risks in multiple myeloma that DNA tests alone miss,” study ...

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by progressive muscle wasting and limb ...

The collaboration will utilise Lundbeck's neuroscience experience and Contera Pharma's oligonucleotide expertise.

An international team led by Monash University researchers has uncovered the genetic code governing the way genetic mutations affect mRNA and result in disease.

With Eli Lilly's recent acquisition of Verve Therapeutics and its PCSK9 candidate, delve into what the target represents.